Less advanced stages of colon cancer in patients with type 2 diabetes mellitus: An unexpected finding?

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 4, 2012, Pages 224-228

  Nagel, J M ^a,b   Bucker S ^a   Wood, M ^c   Stark, R ^d   Goke B ^a   Parhofer, K G ^a   Allgayer, H ^e  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e RehaZentren Baden Württemberg ^*  (Germany)

Author keywords

colon cancer; diagnosis; stage; type 2 diabetes mellitus

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CANCER SCREENING; CANCER STAGING; COLON CANCER; COLONOSCOPY; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; GROUPS BY AGE; HUMAN; LYMPH NODE METASTASIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; CARCINOMA; COLONIC NEOPLASMS; COMORBIDITY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; ODDS RATIO;

EID: 84860230696     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0031-1299704     Document Type: Article

References (31)

1. Parkin D M, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin: 2005; 55 74 108 (Pubitemid 40372904)
2. Haberland J, Bertz J, Wolf U et al. German cancer statistics 2004. BMC Cancer: 2010; 10 52
3. Giovannucci E. Insulin and colon cancer. Cancer Causes Control: 1995; 6 164 179
4. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev: 1994; 3 687 695 (Pubitemid 24377963)
5. Larsson S C, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst: 2005; 97 1679 1687 (Pubitemid 41672234)
6. Berster J M, Goke B. Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem: 2008; 114 84 98 (Pubitemid 351998747)
7. Calle E E, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med: 2003; 348 1625 1638 (Pubitemid 36459468)
8. Bowker S L, Majumdar S R, Veugelers P et al. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider. Diabetes Care: 2006; 29 1990 1991 (Pubitemid 44156679)
9. Meyerhardt J A, Catalano P J, Haller D G et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol: 2003; 21 433 440 (Pubitemid 46606471)
10. Noh G Y, Hwang D Y, Choi Y H et al. Effect of diabetes mellitus on outcomes of colorectal cancer. Journal of the Korean Society of Coloproctology: 2010; 26 424 428
11. Huang Y C, Lin J K, Chen W S et al. Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. Journal of cancer research and clinical oncology: 2011; 137 211 220
12. van de Poll-Franse L V, Houterman S, Janssen-Heijnen M L et al. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer: 2007; 120 1986 1992 (Pubitemid 46418378)
13. Shonka N A, Anderson J R, Panwalkar A W et al. Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer. Med Oncol: 2006; 23 515 519
14. Gross C P, Andersen M S, Krumholz H M et al. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA: 2006; 296 2815 2822 (Pubitemid 44969181)
15. Huang Y C, Lin J K, Chen W S et al. Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol 137 211 220
16. Noh G Y, Hwang D Y, Choi Y H et al. Effect of diabetes mellitus on outcomes of colorectal cancer. J Korean Soc Coloproctol 26 424 428
17. Baron J A, Cole B F, Sandler R S et al. randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med: 2003; 348 891 899 (Pubitemid 36297997)
18. Sandler R S, Halabi S, Baron J A et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med: 2003; 348 883 890 (Pubitemid 36297996)
19. Doran J, Hardcastle J D. Bleeding patterns in colorectal cancer: the effect of aspirin and the implications for faecal occult blood testing. Br J Surg: 1982; 69 711 713 (Pubitemid 13201860)
20. Lewis J D, Capra A M, Achacoso N S et al. Medical therapy for diabetes is associated with increased use of lower endoscopy. Pharmacoepidemiol Drug Saf: 2007; 16 1195 1202 (Pubitemid 350120644)
21. Sieverding M, Matterne U, Ciccarello L. Gender differences in FOBT use: evidence from a large German survey. Z Gastroenterol: 2008; 46 01 S47 S51 (Pubitemid 351548169)
22. Atlas S J, Grant R W, Ferris T G et al. Patient-physician connectedness and quality of primary care. Ann Intern Med: 2009; 150 325 335
23. Fijten G H, Blijham G H, Knottnerus J A. Occurrence and clinical significance of overt blood loss per rectum in the general population and in medical practice. Br J Gen Pract: 1994; 44 320 325 (Pubitemid 24224584)
24. Crosland A, Jones R. Rectal bleeding: prevalence and consultation behaviour. BMJ: 1995; 311 486 488
25. Talley N J, Jones M. Self-reported rectal bleeding in a United States community: prevalence, risk factors, and health care seeking. Am J Gastroenterol: 1998; 93 2179 2183 (Pubitemid 29076871)
26. Baig N, Myers R E, Turner B J et al. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol: 2003; 98 2078 2081 (Pubitemid 37185809)
27. Ferrante J M, McCarthy E P, Gonzalez E C et al. Primary care utilization and colorectal cancer outcomes among medicare beneficiaries. Arch Intern Med: 2011; 171 1747 1757
28. Lysy J, Israeli E, Goldin E. The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol: 1999; 94 2165 2170 (Pubitemid 29374548)
29. München T. Gastrointestinale Tumoren. Vol 8 München Zuckschwerdt: 2010
30. Hauner H, Koster I, von Ferber L. Prevalence of diabetes mellitus in Germany 1998-2001. Secondary data analysis of a health insurance sample of the AOK in Hesse/KV in Hesse. Dtsch Med Wochenschr: 2003; 128 2632 2637
31. Rathmann W, Haastert B, Icks A et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia: 2003; 46 182 189 (Pubitemid 36343881)